Back to RPRX
JOHN G ULLMAN & ASSOCIATES INC → RPRX
JOHN G ULLMAN & ASSOCIATES INC RPRX Position History
Royalty Pharma plc
Quarters held
5
Latest value
$12.8M
Q3 2026
Peak value
$13.7M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $9.5M |
| Q4 2025 | $10.4M |
| Q1 2026 | $13.7M |
| Q2 2026 | $12.4M |
| Q3 2026 | $12.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $12.8M | 262.8K | — | — |
| Q2 2026 | $12.4M | 266.1K | — | — |
| Q1 2026 | $13.7M | 266.9K | — | — |
| Q4 2025 | $10.4M | 270.6K | — | — |
| Q3 2025 | $9.5M | 275.1K | — | — |